PubMed · 1983 · 35 citations · 0 references
MedicineOphthalmologyPharmacologyDiabetologyOcular DiseaseOcular PharmacologyDiabetes ManagementDiabetes PharmacotherapyDiabetic RetinopathyOcular Drug MetabolismOcular PharmacodynamicsOral Antidiabetic AgentsAldose Reductase TargetsAntidiabetic Drug TherapyDiabetes-related ComplicationsDiabetic ComplicationsGlucose Metabolism DisordersNerve Tissue ResponseOcular Manifestations Of DiabetesOral Antidiabetic Medications
Sorbitol, resulting from glucose metabolism through aldose reductase, may play a role in diabetic complications such as cataracts, neuropathy, and vasculopathy. Sulindac (Clinoril) and sorbinil, two inhibitors of aldose reductase, decreased sorbitol formation in cataract or nerve tissue incubated in high glucose TC-199 media. Sulindac, a widely used anti-rheumatic drug, may have clinical applications in preventing diabetic complications.